BiomX Inc. Warrants to purchase one-half of a share of Common Stock
PHGE.WS
PHGE.WS was delisted on the 1st of June, 2023.
9 hedge funds and large institutions have $44.2K invested in BiomX Inc. Warrants to purchase one-half of a share of Common Stock in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
50% less capital invested
Capital invested by funds: $88K → $44.2K (-$43.8K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$184K |
| 2 |
CS
Clear Street
New York
|
+$4.27K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
M
Murchinson
Toronto,
Ontario, Canada
|
-$13K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$51 |
| 3 |
Mariner
Overland Park,
Kansas
|
-$32 |
PHGE.WS Hedge Fund Activity: Q4 2022 in Review
9 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in BiomX Inc. Warrants to purchase one-half of a share of Common Stock (PHGE.WS) for Q4 2022, worth a combined $44.2K — down 50% from $88K a quarter earlier.
Fund positioning in PHGE.WS was balanced in Q4 2022: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was BlueCrest Capital Management, adding an estimated $184K. The largest seller was Murchinson, exiting entirely with an estimated $13K sold.
- 9 institutional investors held BiomX Inc. Warrants to purchase one-half of a share of Common Stock (PHGE.WS) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $44.2K of BiomX Inc. Warrants to purchase one-half of a share of Common Stock stock for Q4 2022, down 50% quarter-over-quarter.
- 1 fund opened new BiomX Inc. Warrants to purchase one-half of a share of Common Stock positions in Q4 2022 and 1 closed out, a net change of 0 holders.
- The largest BiomX Inc. Warrants to purchase one-half of a share of Common Stock buyer in Q4 2022 was BlueCrest Capital Management, an estimated $184K added.
- The largest BiomX Inc. Warrants to purchase one-half of a share of Common Stock seller in Q4 2022 was Murchinson, an estimated $13K sold.
Based on aggregated 13F filings for Q4 2022.